Company news

Proteomics International Laboratories Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

PromarkerD application for Australian MBS to be resubmitted

March 15, 2023

Distribution agreement for PromarkerD in Britain extended

February 14, 2023

December 2022 Quarterly Activities Report and Appendix 4C

January 30, 2023

Letter of intent with Sonic Healthcare USA extended

January 30, 2023

CPT PLA reimbursement code approved in US for PromarkerD

January 2, 2023

UK NICE publishes Medtech Innovation Briefing on PromarkerD

December 13, 2022

AGM Chairmans Address and Investor Presentation

November 24, 2022

PromarkerD patent granted in Hong Kong

November 10, 2022

September 2022 Quarterly Activities Report and Appendix 4C

October 30, 2022

Precision diagnostics facility receives $2m funding boost

October 19, 2022

Proteomics receives $1.7 million in R&D tax incentive

October 16, 2022

New Oesophageal Cancer Diagnostic shows strong performance

September 26, 2022

OxiDx launched to maximise oxidative stress technology

August 28, 2022

Completion of Placement and Exercise of Performance Rights

August 21, 2022

Proteomics raises $8m in highly successful Placement

August 14, 2022

Proteomics signs binding LOI with Sonic Healthcare USA

August 9, 2022

Clinical Utility Study demonstrates PromarkerD test benefits

August 1, 2022

Potential breakthrough blood test for endometriosis

July 31, 2022

June 2022 Quarterly Activities Report and Appendix 4C

July 27, 2022

European PromarkerD patents expanded beyond diabetes

July 24, 2022

Endometriosis clinical validation study readout positive

June 29, 2022

Proteomics secures licence to oesophageal cancer biomarkers

June 20, 2022

PromarkerD manufacturing tech-transfer completed

June 15, 2022

Proteomics awarded $400,000 funding to support manufacturing

May 11, 2022

March 2022 Quarterly Activities Report and Appendix 4C

April 27, 2022

New Clinical Advisory Board for PromarkerD global rollout

April 12, 2022

PromarkerD completes pre-assessment for Medicare rebate

February 21, 2022

Unique panel of biomarkers identified for oesophageal cancer

February 3, 2022

December 2021 Quarterly Activities Report and Appendix 4C

January 26, 2022

Proteomics secures major pharmacokinetic testing contract

December 15, 2021

Proteomics receives $1.2 million in R&D tax incentive

December 13, 2021

PromarkerD distribution network expands to Britain

November 22, 2021

PromarkerD outperforms standard of care tests for DKD

November 4, 2021

Proteomics awarded $100,000 manufacturing funding

November 2, 2021

September 2021 Quarterly Activities Report and Appendix 4C

October 27, 2021

Clinical utility study shows benefit of PromarkerD testing

October 17, 2021

Proteomics contracts Biotem to manufacture PromarkerD kits

August 11, 2021

Proteomics to collaborate to validate test for endometriosis

August 3, 2021

June 2021 Quarterly Activities Report and Appendix 4C

July 29, 2021

Proteomics engages Abcam to manufacture PromarkerD reagents

July 21, 2021

Study shows diabetes drug improves PromarkerD risk scores

July 15, 2021

Reinstatement to Official Quotation

July 2, 2021

Suspension from Official Quotation

June 29, 2021

Modelling shows PromarkerD could save US payers $384 billion

June 24, 2021

Proteomics secures major analytical services contract

May 17, 2021

Major economic health benefit demonstrated for PromarkerD

May 12, 2021

March 2021 Quarterly Activities Report and Appendix 4C

April 28, 2021

ISO 13485 certification received - Manufacturing Update

April 22, 2021

Response to Price Query

February 16, 2021

Proteomics International seeks FDA approval for PromarkerD

February 7, 2021

← Newer news releases · Older news releases →

Decks

The 5 newest of 46 decks. Every deck is listed under its year.